Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$47.71
+5.9%
$45.21
$17.02
$70.26
$155.54M0.1935,964 shs27,791 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.86
+3.4%
$4.70
$4.01
$9.33
$79.90M1.29191,513 shs36,647 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+5.90%+10.67%+11.52%-6.27%+178.52%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.40%+0.83%+0.62%+8.97%-4.14%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2.467 of 5 stars
2.52.00.00.02.61.71.9
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.902 of 5 stars
3.63.00.00.01.80.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
3.00
Buy$56.0017.38% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67140.05% Upside

Current Analyst Ratings Breakdown

Latest SRTS and PDEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$54.00 ➝ $56.00
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$53.84M2.89$1.01 per share47.05$9.03 per share5.28
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.91$0.45 per share10.88$3.41 per share1.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$2.13M$2.8017.0423.16N/A14.61%29.08%16.19%9/4/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1048.6021.13N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest SRTS and PDEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/1/2025Q3 2025
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.47$0.98+$0.51$0.98$17.70 million$17.41 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.28
2.73
1.45
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
47.50%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1403.26 million1.71 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$47.71 +2.66 (+5.90%)
As of 07/3/2025 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.86 +0.16 (+3.40%)
As of 07/3/2025 02:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.